Apoptosis and Necrosis

Critical Care Nephrology, Second Edition

Volumn , Issue , 2008, Pages 186-191

  Devarajan, Prasad ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85166108289     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4252-5.50037-X     Document Type: Chapter

References (42)

1. JF Kerr, AH Wyllie and AR Currie (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 239-257.
2. HM Ellis and HR Horvitz (1986) Genetic control of programmed cell death in the nematode. Cell 44 817-829.
3. P-K Ho and CJ Hawkins (2005) Mammalian initiator apoptotic caspases. FEBS J 272 5436-5453.
4. ZT Schafer and S Kornbluth (2006) The apoptosome: Physiological, developmental, and pathological modes of regulation. Dev Cell 10 549-561.
5. TQ Nhan, WC Liles and SM Schwartz (2006) Physiological functions of caspases beyond cell death. Am J Pathol 169 729-737.
6. MD Tibbetts, L Zheng and MJ Lenardo (2003) The death effector domain protein family: Regulators of cellular homeostasis. Nature Immunol 4 404-409.
7. S Zinkel, A Gross and E Yang (2006) BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13 1351-1359.
8. P Salomoni and AF Khelifi (2006) Daxx: Death or survival protein? Trends Cell Biol 16 97-104.
9. MS Park, BS Kim and P Devarajan (2007) Hypoxia/re-oxygenation injury induces apoptosis of LLC-PK1 cells by activation of caspase-2. Pediatr Nephrol 22 202-208.
10. G Kroemer and SJ Martin (2005) Caspase-independent cell death. Nature Med 11 725-730.
11. P Devarajan (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17 1503-1520.
12. P Saikumar and MA Venkatachalam (2003) Role of apoptosis in hypoxic/ischemic damage in the kidney. Semin Nephrol 6 512-521.
13. GP Kaushal, AG Basnakian and SV Shah (2004) Apoptotic pathways in ischemic acute renal failure. Kidney Int 66 500-505.
14. PC Dagher (2004) Apoptosis in ischemic renal injury: Roles of GTP depletion and p53. Kidney Int 66 506-509.
15. S Supavekin, W Zhang, R Kucherlapati, et al. (2003) Differential gene expression following early renal ischemia/reperfusion. Kidney Int 63 1714-1724.
16. KJ Kelly, Z Plotkin, SL Vulgamott and PC Dagher (2003) P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: Protective role of a p53 inhibitor. J Am Soc Nephrol 14 128-138.
17. M Del Rio, A Imam, M DeLeon, et al. (2004) The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J Am Soc Nephrol 15 41-51.
18. P Hamar, E Song, G Kokeny, et al. (2004) Small interfering RNA targeting Fas protects mice against renal ischemia-reperfusion injury. Proc Natl Acad Sci U S A 101 14883-14888.
19. R Takeda, H Nishimatsu, E Suzuki, et al. (2006) Ghrelin improves renal function in mice with ischemic acute renal failure. J Am Soc Nephrol 17 113-121.
20. Q Wei, XM Yin, MH Wang and Z Dong (2006) Bid deficiency ameliorates ischemic renal failure and delays animal death in C57BL/6 mice. Am J Physiol Renal Physiol 290 F35-F42.
21. AT Burns, DR Davies, AJ McLaren, et al. (1998) Apoptosis in is-chemia/reperfusion injury of human renal allografts. Transplantation 66 872-876.
22. R Oberbauer, M Rohrmoser, H Regele, et al. (1999) Apoptosis of tubular epithelial cells in donor kidney biopsies predicts early renal allograft function. J Am Soc Nephrol 10 2006-2013.
23. C Schwarz, P Hauser, R Steininger, et al. (2002) Failure of Bcl-2 up-regulation in proximal tubular epithelial cells of donor kidney biopsy specimens is associated with apoptosis and delayed graft function. Lab Invest 82 941-948.
24. SC Hoffman, RL Kampen, S Amur, et al. (2002) Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 74 916-923.
25. MP Castaneda, A Swiatecka-Urban, MM Mitsnefes, et al. (2003) Activation of mitochondrial apoptotic pathways in human renal allografts following ischemia-reperfusion. Transplantation 76 50-54.
26. P Hauser, C Schwarz, C Mitterbauer, et al. (2004) Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest 84 353-361.
27. TA Sutton, HE Mang, SB Campos, et al. (2003) Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 285 F191-F198.
28. B Vallet (2003) Bench-to-bedside review: Endothelial cell dysfunction in severe sepsis: A role in organ dysfunction? Crit Care 7 130-138.
29. SV Brodsky, T Yamamoto, T Tada, et al. (2002) Endothelial dysfunction in ischemic acute renal failure: Rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 282 F1140-F1149.
30. DP Basile, K Fredrich, D Weihrauch, et al. (2004) Angiostatin and matrix metalloprotease expression following ischemic acute renal failure. Am J Physiol Renal Physiol 286 F893-F902.
31. A Ortiz, P Justo, A Sanz, et al. (2003) Targeting apoptosis in acute tubular injury. Biochem Pharmacol 66 1589-1594.
32. A Fleischer, A Ghadiri, F Dessauge, et al. (2006) Modulating apoptosis as a target for effective therapy. Mol Immunol 43 1065-1079.
33. S Faubel and CL Edelstein (2005) Caspases as drug targets in ischemic organ injury. Curr Drug Targets Immune Endocr Metabol Disord 5 269-287.
34. DR Green and G Kroemer (2005) Pharmacologic manipulation of cell death: clinical applications insight? J Clin Invest 115 2610-2617.
35. L Bouchier-Hayes, L Lartigue and DD Newmeyer (2005) Mitochondria: Pharmacological manipulation of cell death. J Clin Invest 115 2640-2647.
36. A Letai (2005) Pharmacologic manipulation of Bcl-2 family members to control cell death. J Clin Invest 115 2648-2655.
37. IN Lavrik, A Golks and PH Krammer (2005) Caspases: Pharmacolo-gical manipulation of cell death. J Clin Invest 115 2665-2672.
38. A Jani, D Ljubanivic, SG Faubel, et al. (2004) Caspase inhibition prevents the increase in caspase-3, −2, −8 and −9 activity and apoptosis in the cold ischemic mouse kidney. Am J Transplant 8 1246-1254.
39. NC Hoglen, LS Chen, CD Fisher, et al. (2004) Characterization of IDN-6556 (3-[2-(2-tert-butyl-phenylaminooxalyl)-amino]-propionylamino]-4-oxo-5-(2,3,5,6-tetrafluoro-phenoxy)-pentanoic acid): A liver-targeted caspase inhibitor. J Pharmacol Exp Ther 309 634-640.
40. SM Quadri, L Segall, M de Perrot, et al. (2005) Caspase inhibition improves ischemia-reperfusion injury after lung transplantation. Am J Transplant 5 292-299.
41. EJ Sharples, C Thiemermann and MM Yaqoob (2005) Mechanisms of disease: Cell death in acute renal failure and emerging evidence for a protective role of erythropoietin. Nature Clin Pract Nephrol 1 87-97.
42. CC Cao, XQ Ding, ZL Ou, et al. (2004) In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats. Kidney Int 65 834-845.